Search research articles
Contact Us
Filters
Showing results (341-350 of 706) with videos related to
Page
of 71
Sort By:
Circulation
|
January 13, 2010
Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry
Caroline S Fox, Paul Muntner, Anita Y Chen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 1, 2018
Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction
Nasrien E Ibrahim, Hanna K Gaggin, Alexander Turchin, et al.
Clinical Cardiology
|
May 20, 2008
The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention
Eugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology
|
May 20, 2008
Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention
Eugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
American Heart Journal
|
September 20, 2024
Enrollment strategies in the era of digital revolution: Experience from a remote health management program
Shahzad Hassan, Lee-Shing Chang, Daniel Gabovitch, et al.
Circulation
|
April 2, 2008
Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction
Marc S Sabatine, David A Morrow, Luke J Higgins, et al.
Journal of the American College of Cardiology
|
November 26, 2002
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy
Marc S Sabatine, David A Morrow, Christopher P Cannon, et al.
Circulation
|
August 13, 2003
Soluble CD40L: risk prediction after acute coronary syndromes
Nerea Varo, James A de Lemos, Peter Libby, et al.
American Heart Journal
|
June 7, 2011
Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)
Sean R Wilson, Marc S Sabatine, Stephen D Wiviott, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2022
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose-lowering agent: An analysis from VERTIS CV
Samuel Dagogo-Jack, Christopher P Cannon, David Z I Cherney, et al.
Page
of 71
Search research articles
Search
Showing results (341-350 of 706) with videos related to
Sort By:
Page
of 71
Circulation
|
January 13, 2010
Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry
Caroline S Fox, Paul Muntner, Anita Y Chen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 1, 2018
Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction
Nasrien E Ibrahim, Hanna K Gaggin, Alexander Turchin, et al.
Clinical Cardiology
|
May 20, 2008
The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention
Eugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology
|
May 20, 2008
Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention
Eugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
American Heart Journal
|
September 20, 2024
Enrollment strategies in the era of digital revolution: Experience from a remote health management program
Shahzad Hassan, Lee-Shing Chang, Daniel Gabovitch, et al.
Circulation
|
April 2, 2008
Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction
Marc S Sabatine, David A Morrow, Luke J Higgins, et al.
Journal of the American College of Cardiology
|
November 26, 2002
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy
Marc S Sabatine, David A Morrow, Christopher P Cannon, et al.
Circulation
|
August 13, 2003
Soluble CD40L: risk prediction after acute coronary syndromes
Nerea Varo, James A de Lemos, Peter Libby, et al.
American Heart Journal
|
June 7, 2011
Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)
Sean R Wilson, Marc S Sabatine, Stephen D Wiviott, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2022
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose-lowering agent: An analysis from VERTIS CV
Samuel Dagogo-Jack, Christopher P Cannon, David Z I Cherney, et al.
Page
of 71